Michelle A. Josephson to Coronary Disease
This is a "connection" page, showing publications Michelle A. Josephson has written about Coronary Disease.
Connection Strength
0.195
-
Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease. Am Heart J. 1985 Jan; 109(1):41-5.
Score: 0.055
-
Comparative effects of oral verapamil and propranolol on exercise-induced myocardial ischemia and energetics in patients with coronary artery disease: single-blind placebo crossover evaluation using radionuclide ventriculography. Am Heart J. 1982 Jun; 103(6):978-85.
Score: 0.046
-
Noninvasive detection and localization of coronary stenoses in patients: comparison of resting dipyridamole and exercise thallium-201 myocardial perfusion imaging. Am Heart J. 1982 Jun; 103(6):1008-18.
Score: 0.046
-
Severity of silent myocardial ischemia on ambulatory electrocardiographic monitoring in patients with stable angina pectoris: relation to prognostic determinants during exercise stress testing and coronary angiography. J Am Coll Cardiol. 1988 Nov; 12(5):1169-76.
Score: 0.018
-
Effects of flecainide on ventricular function: clinical and experimental correlations. Am J Cardiol. 1984 Feb 27; 53(5):95B-100B.
Score: 0.013
-
Reproducibility of equilibrium radionuclide ventriculography in patients with coronary artery disease: response of left ventricular ejection fraction and regional wall motion to supine bicycle exercise. Am Heart J. 1982 Sep; 104(3):567-74.
Score: 0.012
-
Hemodynamic effects of flestolol, a titratable short-acting intravenous beta-adrenergic receptor blocker. J Clin Pharmacol. 1988 Mar; 28(3):276-82.
Score: 0.004